[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600307":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":38,"locations":47,"responsibleParty":246,"collaborators":42,"id":248,"slug":249,"hasResults":250,"nctId":251,"briefTitle":252,"officialTitle":253,"acronym":254,"eligibilityCriteria":255,"healthyVolunteers":250,"sex":256,"minAge":257,"maxAge":258,"enrollmentInfo":259,"targetDuration":42,"studyType":262,"phases":263,"briefSummary":265,"conditions":266,"keywords":268,"overallStatus":50,"whyStopped":42,"lastUpdateSubmitDate":270,"lastUpdatePostDateStruct":271,"startDateStruct":274,"completionDateStruct":276,"leadSponsor":278,"locationsCount":279},{"fullName":5,"class":6},"Second Affiliated Hospital of Soochow University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Tirofiban+Oral Dual Antiplatelet Therapy","EXPERIMENTAL","Patients will receive tirofiban in the first 48 hours and then be switched to oral dual antiplatelet therapy thereafter",[13],"Drug: Tirofiban+Oral Dual Antiplatelet Therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"oral dual antiplatelet therapy","ACTIVE_COMPARATOR","Patients will receive oral dual antiplatelet therapy alone",[19],"Drug: Oral Dual Antiplatelet Therapy",[21,27],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Tirofiban will use a loading dose, 0.4 μg\u002Fkg\u002Fmin × 30 minutes, then 0.1μg\u002Fkg\u002Fmin infusion for 47.5 hours; sequential Oral Dual Antiplatelet Therapy (Aspirin 100mg qd; Clopidogrel 75mg qd)",[9],[26],"Tirofiban with Sequential Dual Antiplatelet Therapy",{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Oral Dual Antiplatelet Therapy","Aspirin 100mg qd; Clopidogrel 75mg qd (after first dose of 300mg)",[15],[32,33],"Dual Antiplatelet Therapy","Aspirin plus Clopidogrel",[35],{"name":36,"affiliation":5,"role":37},"Jijun Shi, M.D","PRINCIPAL_INVESTIGATOR",[39,44],{"name":36,"role":40,"phone":41,"phoneExt":42,"email":43},"CONTACT","+86 512 67783689",null,"shijijun2008@126.com",{"name":45,"role":40,"phone":42,"phoneExt":42,"email":46},"Yongjun Cao, M.D, PhD","yongjuncao@126.com",[48,64,77,90,103,116,128,135,144,153,162,171,180,188,197,209,222,234],{"facility":49,"status":50,"city":51,"state":52,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Suzhou Municipal Hospital of Anhui Province","RECRUITING","Suzhou","Anhui","China","CN",{"type":56,"coordinates":57},"Point",[58,59],116.97889,33.63611,{"lat":59,"lon":58},[62],{"name":63,"role":40,"phone":42,"phoneExt":42,"email":42},"Yingzhi Liang",{"facility":65,"status":50,"city":66,"state":67,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Second Hospital of Hebei Medical University","Shijiazhuang","Hebei",{"type":56,"coordinates":69},[70,71],114.47861,38.04139,{"lat":71,"lon":70},[74],{"name":75,"role":40,"phone":42,"phoneExt":42,"email":76},"Zichun Zhao","zhaozichun83@163.com",{"facility":78,"status":50,"city":79,"state":80,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Taikang Xian People's Hospital","Zhoukou","Henan",{"type":56,"coordinates":82},[83,84],114.63333,33.63333,{"lat":84,"lon":83},[87],{"name":88,"role":40,"phone":42,"phoneExt":42,"email":89},"Haiyang Shu","shuhaiyang1989@163.com",{"facility":91,"status":50,"city":92,"state":93,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"WuYuan County People's Hospital","Bayan Nur","Inner Mongolia",{"type":56,"coordinates":95},[96,97],107.38599,40.74143,{"lat":97,"lon":96},[100],{"name":101,"role":40,"phone":42,"phoneExt":42,"email":102},"Yongming Chen","cyongm2010@163.com",{"facility":104,"status":50,"city":105,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":107,"geoPoint":111,"contacts":112},"Huai'an First People's Hospital","Huai'an","Jiangsu",{"type":56,"coordinates":108},[109,110],119.01917,33.58861,{"lat":110,"lon":109},[113],{"name":114,"role":40,"phone":42,"phoneExt":42,"email":115},"Kun An","ankunsjnk@njmu.edu.cn",{"facility":117,"status":50,"city":118,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"Jiangsu Province (Suqian) Hospital","Suqian",{"type":56,"coordinates":120},[121,122],118.29583,33.94917,{"lat":122,"lon":121},[125],{"name":126,"role":40,"phone":42,"phoneExt":42,"email":127},"Dan Li","343129771@qq.com",{"facility":5,"status":50,"city":51,"state":106,"zip":129,"country":53,"countryCode":54,"cosmosGeoPoint":130,"geoPoint":134,"contacts":42},"215004",{"type":56,"coordinates":131},[132,133],120.59538,31.30408,{"lat":133,"lon":132},{"facility":136,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":137,"geoPoint":139,"contacts":140},"Affiliated Jiangsu Shengze Hospital of Nanjing Medical University",{"type":56,"coordinates":138},[132,133],{"lat":133,"lon":132},[141],{"name":142,"role":40,"phone":42,"phoneExt":42,"email":143},"Shenglong Wang","2837012866@qq.com",{"facility":145,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":146,"geoPoint":148,"contacts":149},"Changshu No.1 People's Hospital",{"type":56,"coordinates":147},[132,133],{"lat":133,"lon":132},[150],{"name":151,"role":40,"phone":42,"phoneExt":42,"email":152},"Taosheng Lu","lutaosheng@163.com",{"facility":154,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":155,"geoPoint":157,"contacts":158},"First People's Hospital of Kunshan",{"type":56,"coordinates":156},[132,133],{"lat":133,"lon":132},[159],{"name":160,"role":40,"phone":42,"phoneExt":42,"email":161},"Guihua Miao","mghmty@126.com",{"facility":163,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":164,"geoPoint":166,"contacts":167},"Suzhou Ninth People's Hospital",{"type":56,"coordinates":165},[132,133],{"lat":133,"lon":132},[168],{"name":169,"role":40,"phone":42,"phoneExt":42,"email":170},"Guojie Zhai","125461985@qq.com",{"facility":172,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":173,"geoPoint":175,"contacts":176},"Suzhou Xiangcheng People's Hospital",{"type":56,"coordinates":174},[132,133],{"lat":133,"lon":132},[177],{"name":178,"role":40,"phone":42,"phoneExt":42,"email":179},"Xiaoyun Han","15895561709@163.com",{"facility":181,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":182,"geoPoint":184,"contacts":185},"Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine",{"type":56,"coordinates":183},[132,133],{"lat":133,"lon":132},[186],{"name":42,"role":40,"phone":42,"phoneExt":42,"email":187},"15850297009@139.com",{"facility":189,"status":50,"city":51,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":190,"geoPoint":192,"contacts":193},"Zhangjiagang Hospital of Traditional Chinese Medicine",{"type":56,"coordinates":191},[132,133],{"lat":133,"lon":132},[194],{"name":195,"role":40,"phone":42,"phoneExt":42,"email":196},"Yaming Sun","sunyaming2001@126.com",{"facility":198,"status":50,"city":199,"state":106,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":200,"geoPoint":204,"contacts":205},"Taixing Second People's Hospital","Taizhou",{"type":56,"coordinates":201},[202,203],119.90812,32.49069,{"lat":203,"lon":202},[206],{"name":207,"role":40,"phone":42,"phoneExt":42,"email":208},"Ligong Ji","420643682@qq.com",{"facility":210,"status":50,"city":211,"state":212,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":213,"geoPoint":217,"contacts":218},"Nuclear Industry 417 Hospital","Xi'an","Shaanxi",{"type":56,"coordinates":214},[215,216],108.92861,34.25833,{"lat":216,"lon":215},[219],{"name":220,"role":40,"phone":42,"phoneExt":42,"email":221},"Tao Xu","xutao_417@126.com",{"facility":223,"status":50,"city":224,"state":212,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":225,"geoPoint":229,"contacts":230},"First People's Hospital of Xianyang","Xianyang",{"type":56,"coordinates":226},[227,228],108.70261,34.33778,{"lat":228,"lon":227},[231],{"name":232,"role":40,"phone":42,"phoneExt":42,"email":233},"Yugang Wang","yugangwang@126.com",{"facility":235,"status":50,"city":236,"state":42,"zip":42,"country":53,"countryCode":54,"cosmosGeoPoint":237,"geoPoint":241,"contacts":242},"Second Hospital of Tianjin Medical University","Tianjin",{"type":56,"coordinates":238},[239,240],117.17667,39.14222,{"lat":240,"lon":239},[243],{"name":244,"role":40,"phone":42,"phoneExt":42,"email":245},"Dongliang Wang","wdl.021705@163.com",{"type":247,"investigatorFullName":42,"investigatorTitle":42,"investigatorAffiliation":42,"oldNameTitle":42,"oldOrganization":42},"SPONSOR","100600307","phase-4-tirofiban-with-sequential-dual-antiplatelet-therapy-in-mild-stroke-100600307",false,"NCT07095790","Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke","Tirofiban With Sequential Dual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Alone in Mild Acute Ischemic Stroke (TiMIS): A Multicenter, Open-Label, Blinded-Endpoint, Parallel-Controlled, Randomized Clinical Trial","TiMIS","Inclusion Criteria:\n\n1. Age: 18-80 years old.\n2. Acute mild non-cardioembolic stroke.\n3. NIHSS score ≤5.\n4. Time from onset to randomization of ≤48 hours; if the time of onset is unknown, time from the last known time of being well to randomization of ≤48 hours.\n5. The investigational drug can be administered within 48 hours of symptom onset.\n6. Signed informed consent by the patient or legally authorized representative.\n\nExclusion Criteria:\n\n1. Received or planned to receive intravenous thrombolysis or bridging therapy (with subsequent endovascular treatment)\n2. Intracranial hemorrhage confirmed by imaging.\n3. Pre-stroke modified Rankin Scale (mRS) score ≥2.\n4. Any confirmed cardioembolic source, including chronic or paroxysmal atrial fibrillation, sick sinus syndrome, mitral stenosis, mechanical heart valve, infective endocarditis, intracardiac thrombus or vegetation, myocardial infarction within 3 months, dilated cardiomyopathy, left atrial spontaneous echo contrast, ejection fraction \\\u003C30%.\n5. History of primary intracerebral hemorrhage.\n6. History of other intracranial hemorrhage (intraventricular, subarachnoid, epidural, or subdural hemorrhage).\n7. Untreated or inadequately treated intracranial aneurysm or vascular malformation.\n8. Major systemic bleeding within 30 days.\n9. Active bleeding, including laboratory evidence of coagulopathy (platelet count \\\u003C100 × 10⁹\u002FL, activated partial thromboplastin time \\>50 seconds, or international normalized ratio \\>1.7), or treatment with direct oral anticoagulants within the preceding 48 hours.\n10. Major surgery within 14 days.\n11. Persistently elevated blood pressure (systolic \\>180 mmHg or diastolic \\>110 mmHg) despite treatment.\n12. Baseline platelet count \\\u003C100 × 10⁹\u002FL.\n13. Severe renal dysfunction (glomerular filtration rate \\\u003C30 mL\u002Fmin or serum creatinine \\>220 μmol\u002FL \\[2.5 mg\u002FdL\\]).\n14. Known allergy or contraindication to tirofiban or aspirin.\n15. Current pregnancy or lactation.\n16. Any intracranial tumor (except asymptomatic meningiomas ≤1.5 cm in diameter).\n17. Any terminal illness with life expectancy \\\u003C6 months.","ALL","18 Years","80 Years",{"count":260,"type":261},580,"ESTIMATED","INTERVENTIONAL",[264],"PHASE4","This study aims to evaluate whether initiating intravenous tirofiban within 48 hours of onset (with a 48-hour infusion), followed by sequential DAPT, can improve the likelihood of excellent functional outcomes (modified Rankin Scale score 0-1) in mild stroke patients, compared with standard DAPT therapy based on current guidelines.",[267],"Mild Stroke",[269],"Tirofiban; Dual Antiplatelet Therapy; Mild Stroke","2025-07-23",{"date":272,"type":273},"2025-07-31","ACTUAL",{"date":275,"type":261},"2025-08-30",{"date":277,"type":261},"2027-05-31",{"name":5,"class":6},18]